- Lobbying
- David AND Rudloff
Lobbying Arrangements Results for 'David Rudloff'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Prescription drug reimbursement issues |
TerSera Therapeutics
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to diagnostic testing. |
CytoSPAR LLC
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to diagnostic tests. |
Checkable Medical Inc
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Education about rare disease therapies |
Akouos, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to diagnostic tests. |
Premier Biotech Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to pharmaceutical drugs |
Cumberland Pharmaceuticals
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details General FDA issues |
PolarityTE, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to COVID-19 testing |
Avellino Labs USA
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issue related to FDA regulations |
Genus Medical Technologies
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to dental and oral health products. |
Candid Care Co.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to drug development |
Nymox Pharmaceutical Corporation
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to medical device cleaning |
Novozymes North America, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation |
Nevro
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to pharmaceutical drugs |
Genus Lifesciences
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details FDA drug approval process; Issues related to the opioid epidemic Issues related to Defense Health Agency |
AcelRx Pharmaceuticals, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to COVID-19 vaccine development |
Vaxart Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to regulation of diagnostic tests |
Healgen Scientific
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to hospitals |
Quorum Health Corp.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to FDA and cannabidiol (CBD) |
Rapid Therapeutic Science Laboratories
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022 Issues related to the regulation of gene therapies; newborn screening; FDA appropriations |
Institute for Gene Therapies
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to pharmaceutical drugs |
BioDelivery Sciences International
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to vaccine development. |
Codagenix, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to diabetes and cardiovascular disease |
Boehringer Ingelheim Pharmaceuticals, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to the pharmaceutical industry issues related to Medicare drug reimbursement |
Supernus Pharmaceuticals Inc
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to pharmaceutical drugs |
Collegium Pharmaceutical
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to the National Defense Authorization Act for FY 2024 issues related to health care diagnostics |
Illumina, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to medical devices, prosthesis, and orthotics |
Ottobock HealthCare LP
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to Medicare coverage of Radiology Assistants; HR3657, Medicare Access to Radiology Care Act |
The American Registry of Radiologic Technologists
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details medical device manufacturing, servicing, and sterilization issues; FDA modernization |
Steris Corporation
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues Related to Defense and Human Performance |
Momentous
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Medicare reimbursement of pharmaceuticals general issues of interest to pharmaceutical companies |
scPharmaceuticals, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to eye and wound care |
BioTissue
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to diagnostic testing. |
StemExpress LLC
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details FDA issues Medicare reimbursement issues |
Eagle Pharmaceuticals Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare Part B and Part D Issues related to the pharmaceutical industry |
Biogen Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to technology and manufacturing issues related to tariffs |
Tek84
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to approval of combination products |
Neurotech Pharmaceuticals
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare coverage |
Lifeward (formerly known as ReWalk Robotics, Inc.)
medical device |
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues relating to rulemaking around Single-use Package Drugs; Issues related to implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain... |
Endo Pharmaceuticals Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to Medicare ESRD benefit and chronic kidney disease management Issues related to medication affordability and access |
Ardelyx, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to FDA and rare diseases |
Pharming Healthcare, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details General Issues of interest to pharmaceutical companies Medicare reimbursement of pharmaceuticals |
Organon & Co.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to implementation of the Inflation Reduction Act of 2022, Issues relating to Medicare Part B and Medicare Part D drug pricing reforms. |
We Work for Health
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to combination product development |
Aurion Biotech
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to pharmaceutical drugs |
Amgen Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to pharmaceutical drugs |
SPARC
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to medical devices |
Medical Device Manufacturers Association
medical devices |
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to reimbursement for eye care procedures |
iOR Partners
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to FDA enforcement Issues related to medical device reimbursement |
Glaukos Corporation (FKA Avedro, Inc.)
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare payment for/access to radiation therapy services ARPA-H Issues related to Section 301 tariffs |
Accuray Incorporated
|
JEFFREY J. KIMBELL AND ASSOCIATES |